ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 281613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 281613; 2) Community: the network communities that were significantly associated with the response to NSC 281613; 3) Molecule: the relationships between components within communities and NSC 281613; 4) MDR: the compounds that were significantly associated with the NSC 281613.

NSC Compound Enrichment Correlation
NSC 672140 Null 0.0392716453377535 0.15429537
NSC 676345 Pyrimidine-2,4-diamine, 6-chloro-N(4)- [[1-(hydroxymethyl)-3-(2-phenylethyl)cyclobutyl]methyl]- 0.0392716453377535 0.00053192588
NSC 697912 5-Fluoro deoxy uridine 10mer 0.0392716453377535 0.45943588
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.0392716453377535 0.088797209
NSC 717953 Null 0.0392716453377535 -0.32600008
NSC 718630 Null 0.0392716453377535 0.52219782
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0392716453377535 -0.0077680663
NSC 722996 2-(4-chloro-benzyl)-1H-naphth[2,3-d]imidazole 0.0392716453377535 0.23646098
NSC 726217 Combretastatin A4-analogue 0.0392716453377535 0.18087574
NSC 729166 N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide 0.0392716453377535 -0.091361485
Total:61  Current:50    [First] [Prev] [Next] [Last]